Page 35 - CJO_DIABETES_FRENCH_W17
P. 35
SOINS AUX PATIENTS
2015;31(6):1481-4. doi:10.12669/pjms.316.8204. 2005;19(1):45-51.
172. Giusti C. Transient hyperopic refractive changes in newly diag- 197. Yildirim M, Kilic D, Dursun M, Dursun B. Diabetic papillopathy
nosed juvenile diabetes. Swiss Med Weekly 2003;133:200–20. treated with intravitreal ranibizumab. Int Med Case Rep J 2017; 10,
173. Manaviat M, Rashidi M, Afkhami-Ardekani M, Shoja M. Prevalence 99-103.
of dry eye syndrome and diabetic retinopathy in type 2 diabetic 198. Kim M, Lee J, Lee S. Diabetic papillopathy with macular edema
patients. BMC Ophthalmol 2008;8:10. doi 10.1186/1471-2415-8-10 treated with intravitreal ranibizumab. Clin Ophthalmol 2013; 7:2257-
174. Kaiserman I, Kaiserman N, Nakar S, Vinker S. Dry eye in diabetic 60.
patients. Am J Ophthalmol 2005;139, 498-503. 199. Jacobson D, Vierkant R, Belongia E. A nonarteritic anterior
175. Canadian Association of Optometrists. Canadian Dry Eye Consen- ischemic optic neuropathy. A case-control study of potential
sus Panel. 2014. National Dry Eye Disease Guidelines for Canadian risk factors. Arch Ophthalmol 1997;115, 1403-7. doi:10.1001/ar-
Optometrists. Canadian Journal of Optometry Special Supplement chopht.1997.01100160573008
76(1). Accessed online March 8, 2017 at: https://opto.ca/sites/de- 200. Atkins E, Bruce B, Newman N, Biousse V. Treatment of nonarteritic
fault/files/resources/documents/cjo_dry_eye_supplement_2014.pdf anterior ischemic optic neuropathy. Surv Ophthalmol 2010;55:47-63.
176. Georgakopoulos CD, Makri OE, Pagoulatos D, et al. Effect of 201. Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic
omega-3 fatty acids dietary supplementation on ocular surface and syndrome – a systematic review. Med Sci Monit 2012;18(8): RA138-
tear film in diabetic patients with dry eye. J Am Coll Nutr 2016;1-6. RA144.
Doi:10.1080/07315724.2016.1170643 202. Watanabe K, Hagura R, Akanuma Y, et al. Characteristics of cranial
177. Sacchetti M, Lambiase A. Diagnosis and management of neuro- nerve palsies in diabetic patients. Diabetes Res Clin Pract 1990;10:
trophic keratitis. Clin Ophthalmol 2014;8:571-9. 19-27.
178. O’Donnell C, Efron N. Diabetes and contact lens wear. Clin Exp 203. Tamhankar MA, Biousse V, Ying GS, et al. Isolated third, fourth, and
Optom 2012;95, 328-37. sixth cranial nerve palsies from presumed microvascular versus
179. Chew EY, Benson WE, Remaley NA, et al. Results after lens extrac- other causes: A prospective study. Ophthalmology 2013;120:2264-9.
tion in patients with diabetic retinopathy. Arch Ophthalmol 1999;117, 204. Trigler L, Siatkowski RM, Oster AS, et al. Retinopathy in patients
1600. doi:10.1001/archopht.117.12.1600 with diabetic ophthalmoplegia. Ophthalmology 2003;110:145-50.
180. Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A. Cataract 205. Galtrey C, Schon F, Nitkunan A. Microvascular non-arteritic ocular
surgery in patients with diabetic retinopathy: Visual outcome, pro- motor nerve palsies - What we know and how should we treat?
gression of diabetic retinopathy, and incidence of diabetic macular Neuro-Ophthalmology 2014;39:1-11. http://dx.doi.org/10.3109/016581
oedema. Graefe’s Arch Clin Exp Ophthalmol 2002;240:735-8. doi: 07.2014.963252
10.1007/s00417-002-0530-7
181. Mozaffarieh M, Heinzl H, Sacu S, Wedrich A. Clinical outcomes of
phacoemulsification cataract surgery in diabetes patients: Visual
function (VF-14), visual acuity and patient satisfaction. Acta Oph-
thalmol Scand 2005;83, 176-83.
182. Kim S, Equi R, Bressler N. Analysis of macular edema after cataract
surgery in patients with diabetes using optical coherence tomogra-
phy. Ophthalmology 2007;114, 881-9.
183. Lanzagorta-Aresti A, Palacios-Pozo E, Menezo Rozalen JL, Navea-
Tejerina A. Prevention of vision loss after cataract surgery in dia-
betic macular edema with intravitreal bevacizumab: A pilot study.
Retina 2009;29(4):530-5. doi: 10.1097/IAE.0b013e31819c6302
184. Mittra R, Borrillo J, Dev S, Mieler W, Koenig S. Retinopathy pro-
gression and visual outcomes after phacoemulsification in patients
with diabetes mellitus. Arch Ophthalmol 2000;118, 912-917. doi:10-
1001/pubs.Ophthalmol.-ISSN-0003-9950-118-7-ecs90087
185. Ostri C, Lund-Andersen H, Sander B, Cour M. Phacoemulsifica-
tion cataract surgery in a large cohort of diabetes patients: Visual
acuity outcomes and prognostic factors. J Cataract Refract Surg
2011;37(11)2006-12.
186. Skarbez K, Priestly Y, Hoepf M, Koevary S. Comprehensive review
of the effects of diabetes on ocular health. Expert Rev Ophthalmol
2010;5, 557-77.
187. Yoshida M, Kimura H, Kyuk K, Ito M. Combined effect of vitamin E
and insulin on cataracts of diabetic rats fed a high cholesterol diet.
Biol Pharm Bull 2004 Mar;27(3):338-44.
188. Menchini U, Cappelli S, Virgili G. Cataract surgery and diabetic
retinopathy. Semin Ophthalmol 2003;18(3):103–8.
189. Barkana Y, Belkin M. Selective laser trabeculoplasty. Surv Ophthal-
mol 2007;52:634-54.
190. Koucheki B, Hashemi H. Selective laser trabeculoplasty in the treat-
ment of open-angle glaucoma. J Glaucoma 2012 Jan;21(1):65-70.
doi:10.1097/IJG.0b013e3182027596. PubMed PMID: 21278588.
191. Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeo-
sis iridis from a single bevacizumab (Avastin) injection. Retina 2006
Mar;26(3):354-6.
192. Olmos LC, Sayed MS, Moraczewski AL, et al. Long-term outcomes
of neovascular glaucoma treated with and without intravitreal
bevacizumab. Eye 2016;30:463-72.
193. Rodrigues G, Abe RY, Zangalli C, et al. Neovascular glaucoma: A
review. Int J Retina Vitr 2016;2, 26.
194. Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus.
World J Diabetes 2015;6(1):92-108.
195. Bayraktar Z, Alacali N, Bayraktar S. Diabetic papillopathy in type 2
diabetic patients. Retina 2002; 22(6):752-8.
196. Mansour A, El-Dairi M, Shehab M, Shanih H, Shaaban J, Anto-
nios S. Periocular corticosteroids in diabetic papillopathy. Eye
CANADIAN JOURNAL of OPTOMETRY | REVUE CANADIENNE D’OPTOMÉTRIE VOL. 79 SUPPLEMENT 2, 2017 35
36908_CJO_DIABETES November 15, 2017 7:34 AM APPROVAL: ___________________ DATE: ___________________